Answers are grounded in this paper and cite their sources.
Objective To investigate the effect of oxymatrine (OMT) on cerebral vasospasm in rats with subarachnoid hemorrhage (SAH) and its related mechanism. Methods Two hundred rats were randomly divided into the sham group, SAH group, low and high dose treatment groups with 50 rats in each group. The SAH rat model was established by two injections of the autogenous blood into the cisterna magna, and rats in the sham group were only injected with the same volume saline twice. After surgery, the other three groups were given an intraperitoneal injection of 1 ml 0.9% sodium chloride, 60 or 120 mg/kg OMT, respectively. Ten rats from each group were sacrificed at 1, 3, 5, 7 and 10 d. The diameter of basilar artery was measured and the expression levels of nuclear factor-kappa B (NF-κB), extracellular signal-regulated kinase (ERK) 1/2, p38 mitogen activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK), interleukin-1beta (IL-1β), IL-6 and tumor necrosis factor-alpha (TNF-α) mRNA in endothelial cells were detected. Results At day 3, 5, 7 and 10 after surgery, the significant differences were found in the diameter of basilar artery (F = 11.897, 28.957, 14.785, 8.381; all P 0.05). Conclusions OMT could inhibit cerebral vasospasm of rats with SAH. It may reduce vascular inflammatory reaction of basilar artery via OMT-depressed NF-κB, ERK1/2, p38MAPK and JNK signaling pathways in cerebrovascular endothelial cells.
No takes yet. Share an insight, caveat, or question.
Xianqiang et al. (2016) studied this question.
Synapse has enriched 9 related papers. Consider them for comparative context: